Inmode Ltd
INMD
View Detailed Chart
14.620USD
+0.150+1.04%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
924.12MMarket Cap
6.94P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.04%
5 Days
+1.81%
1 Month
+3.98%
6 Months
+3.91%
Year to Date
-12.46%
1 Year
-14.10%
View Detailed Chart
TradingKey Stock Score of Inmode Ltd
Currency: USD Updated: 2025-12-26Key Insights
Inmode Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 78/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 16.80.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Inmode Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Hold
Current Rating
16.800
Target Price
+16.99%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Inmode Ltd Highlights
StrengthsRisks
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Undervalued
The company’s latest PE is 6.94, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 33.37M shares, decreasing 50.57% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.15K shares of this stock.
Inmode Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Inmode Ltd Info
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Ticker SymbolINMD
CompanyInmode Ltd
CEOMizrahy (Moshe)
Websitehttps://inmodemd.com/
FAQs
What is the current price of Inmode Ltd (INMD)?
The current price of Inmode Ltd (INMD) is 14.620.
What is the symbol of Inmode Ltd?
The ticker symbol of Inmode Ltd is INMD.
What is the 52-week high of Inmode Ltd?
The 52-week high of Inmode Ltd is 19.780.
What is the 52-week low of Inmode Ltd?
The 52-week low of Inmode Ltd is 13.140.
What is the market capitalization of Inmode Ltd?
The market capitalization of Inmode Ltd is 924.12M.
What is the net income of Inmode Ltd?
The net income of Inmode Ltd is 181.28M.
Is Inmode Ltd (INMD) currently rated as Buy, Hold, or Sell?
According to analysts, Inmode Ltd (INMD) has an overall rating of Hold, with a price target of 16.800.
What is the Earnings Per Share (EPS TTM) of Inmode Ltd (INMD)?
The Earnings Per Share (EPS TTM) of Inmode Ltd (INMD) is 2.108.
Related Instruments
+1.30%
+0.29%
+0.03%
+0.11%
-0.49%
-0.05%
-0.13%
-0.75%
+0.67%
+0.59%
+1.91%
+0.59%
+0.34%
+0.09%
+0.04%
+0.64%
+0.26%
+0.05%
+0.26%
+0.67%
